Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

RES October 30, 2025

RPC Inc. Q3 2025 Earnings Call - Broad-Based Revenue Growth Amid Market Uncertainty

RPC Inc. reported a 6% sequential revenue increase in Q3 2025, driven primarily by pressure pumping, coiled tubing, and downhole tools, which together represent a diversified and geographically broad ...

  • Q3 2025 revenues rose 6% sequentially to $447.1 million, led by pressure pumping, coiled tubing, and downhole tools.
  • Pressure pumping accounted for 27.9% of revenue but is now a smaller portion of total business, reflecting strategic de-emphasis.
  • Service lines other than pressure pumping represented 72% of revenue and grew 3% sequentially.
  • +10 more takeaways
DHT October 30, 2025

DHT Holdings Inc. Q3 2025 Earnings Call - VLCC Market Strength and Strategic Financing Bolster Outlook

DHT Holdings closed Q3 2025 with robust earnings, reporting adjusted EBITDA of $57.7 million and a net profit of $29.5 million after adjustments. The combined time charter equivalent (TCE) rate averag...

  • DHT reported Q3 2025 revenues of $79.1 million on TCE basis and adjusted EBITDA of $57.7 million.
  • Net income after adjustments was $29.5 million, or $0.18 per share, reflecting strong profitability.
  • Average combined TCE rate for Q3 was $40,500 per day, with spot rates at $38,700 and time charters at $42,800 per day.
  • +12 more takeaways
GCI October 30, 2025

Gannett Co. Q3 2025 Earnings Call - Digital Revenues Nearing 50% With Pivotal AI Licensing Partnerships and Debt Below $1 Billion

Gannett's Q3 2025 earnings reveal critical shifts in digital revenue composition, now approaching 50% of total revenues—a historic milestone. Despite a revenue timing shift from Q3 to Q4, driven by la...

  • Gannett's total debt fell below $1 billion in Q3 2025 for the first time since its 2019 merger, marking a major balance sheet milestone.
  • Digital revenues reached 47% of total revenues in Q3, an all-time high, and are expected to surpass 50% in Q4 2025 and beyond.
  • A $100 million cost reduction program was fully implemented, with full benefits expected to drive significant year-over-year adjusted EBITDA growth in Q4.
  • +12 more takeaways
FMCC October 30, 2025

Freddie Mac Q3 2025 Earnings Call - Strong Liquidity Boost and Rising Credit Reserves Mark a Mixed Quarter

Freddie Mac reported a solid $2.8 billion net income in Q3 2025, underpinning its $68 billion net worth and a $3.62 trillion mortgage portfolio. The firm injected $124 billion of liquidity into the U....

  • Freddie Mac’s net income was $2.8 billion in Q3 2025, down 11% year-over-year due to increased credit loss provisions.
  • The mortgage portfolio grew to $3.62 trillion, supporting $124 billion liquidity to the housing market, up 17% from the prior quarter.
  • The number of families helped rose 33% to 483,000, with 50% of primary residence buyers being first-time homebuyers.
  • +9 more takeaways
BMY October 30, 2025

Bristol Myers Squibb Q3 2025 Earnings Call - Strong Growth Portfolio Boosts Revenue Guidance Amid Major Pipeline Catalysts

Bristol Myers Squibb delivered a robust third quarter, powered by a 17% sales increase in its growth portfolio driven by immuno-oncology, hematology, cardiovascular, and neuroscience assets. The compa...

  • Q3 sales reached approximately $12.2 billion, marking strong demand across multiple portfolios.
  • Growth portfolio sales increased 17% year-over-year, led by immuno-oncology (Opdivo, Qvantig), hematology (Reblozyl, Breyanzi), and cardiovascular (Camzyos) drugs.
  • Opdivo sales rose 6%, boosted by MSI-high colorectal cancer uptake and expanded indications.
  • +12 more takeaways
SILC October 30, 2025

Silicom Q3 2025 Earnings Call - Design Win Momentum Paves Way for 2026 Double-Digit Growth

Silicom reported a solid Q3 2025 with $15.6 million in revenue, reflecting a 6% year-over-year increase and maintaining full-year momentum with eight major design wins secured thus far. The company em...

  • Silicom reported Q3 2025 revenues of $15.6 million, a 6% increase from Q3 2024, within the upper half of its guidance range.
  • The company achieved eight major new design wins year-to-date 2025, surpassing its lower full-year target and nearing the upper end with two months remaining.
  • Management set an ambitious goal for 2026 to secure seven to nine additional design wins across all product lines including FPGA Solutions, Smart NICs, and Edge Networking Systems.
  • +10 more takeaways
THRY October 30, 2025

Thryv Holdings Q3 2025 Earnings Call - SaaS Growth Strengthens Amid Transition and AI Innovation

Thryv Holdings reported solid third quarter 2025 SaaS revenue growth of 33% year over year, driven by a 14% increase excluding Keap's contribution. The company continues its transformation from legacy...

  • Thryv’s SaaS reported $115.9 million revenue in Q3 2025, up 33% YoY, with Keap contributing $16.8 million.
  • Excluding Keap, Thryv’s SaaS business grew 14% YoY, showing solid core SaaS growth.
  • SaaS adjusted gross margin rose to 73%, an 80 basis point increase YoY, indicating improving profitability.
  • +17 more takeaways
PHAT October 30, 2025

Phathom Pharmaceuticals Q3 2025 Earnings Call - Strategic Shift to Gastroenterology Drives 25% Revenue Growth with 43% Expense Reduction

Phathom Pharmaceuticals reported strong Q3 2025 results, marked by a strategic pivot towards focusing on gastroenterology (GI) specialists to deepen adoption of VOQUEZNA. The company delivered 25% qua...

  • Phathom delivered 25% quarter-over-quarter revenue growth in Q3 to $49.5 million, beating expectations and narrowing full-year guidance to the upper half of $170-$175 million.
  • Cash operating expenses were reduced by 43% quarter-over-quarter to $49.3 million, beating the under $60 million target; cash usage fell 77% to under $15 million.
  • A strategic pivot focuses sales efforts on gastroenterology (GI) physicians, who now represent 70% of prescriptions; sales territories were realigned to better cover high-density GI areas and reduce primary care focus on unproductive physicians.
  • +12 more takeaways
CLMB October 30, 2025

Climb Global Solutions Q3 2025 Earnings Call - Double-Digit Organic Growth and Targeted M&A Pipeline Signal Strong Finish

Climb Global Solutions delivered an eighth consecutive quarter of double-digit organic growth buoyed by the Douglas Stewart Software acquisition and a rigorous vendor selection strategy focused on inn...

  • Climb Global Solutions achieved double-digit organic growth in Q3 2025, sustained for eight consecutive quarters.
  • The acquisition of Douglas Stewart Software (DSS) in July 2024 continues to contribute meaningfully to revenue and growth.
  • Q3 gross billings rose 8% year-over-year to $504.6 million; net sales increased 35% to $161.3 million, aided by organic growth and acquisitions.
  • +11 more takeaways
BDC October 30, 2025

Belden Inc. Q3 2025 Earnings Call - Record Revenue and EPS Highlight Solutions Transformation Momentum

Belden Inc. posted a robust third quarter in 2025, surpassing guidance with record revenue of $698 million, up 7% year over year, and adjusted EPS climbing 16% to $1.97. The company's transformation i...

  • Belden achieved record third quarter revenue at $698 million, a 7% year-over-year increase, beating high-end guidance.
  • Adjusted EPS rose 16% year-over-year to $1.97, reflecting strong profitability and operational execution.
  • Organic revenue growth was 4%, with Automation Solutions segment leading at 10% organic growth driven by discrete manufacturing and industrial markets.
  • +13 more takeaways